A Multiple-Dose Clinical Trial to Study the Effect of MK-1439 (Doravirine) on Methadone Pharmacokinetics
Phase of Trial: Phase I
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Doravirine (Primary) ; Methadone
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Merck Sharp & Dohme
- 27 Oct 2017 Results presented at the 16th European AIDS Conference
- 01 Jul 2016 Status changed from active, no longer recruiting to completed.
- 08 Jun 2016 Status changed from recruiting to active, no longer recruiting.